Prof. Vladimir N. Anisimov, M.D., Ph.D.
Biography & Research Background
Prof. Vladimir N. Anisimov is a researcher at the N.N. Petrov Research Institute of Oncology (St. Petersburg, Russia). He has been instrumental in characterizing the geroprotective and oncostatic properties of Epithalon in animal models, providing decades of critical evidence that while Epithalon extends telomeres, it does not promote cancer — paradoxically inhibiting spontaneous tumor development and extending lifespan in mice. His work established the 'Epithalon Paradox' in gerontological research. Key publications include 'Effect of Epitalon on biomarkers of aging, life span and spontaneous tumor incidence in SHR mice' (Biogerontology, 2003) and 'Inhibitory effect on HER-2/neu mammary tumors' (2002). Prof. Vladimir Anisimov is referenced as a leading scientist in Epithalon research. In no way is this doctor/scientist endorsing or advocating the purchase, sale, or use of this product for any reason. There is no affiliation or relationship, implied or otherwise, between Pure US Peptide and this doctor.
External Profiles
Authored Research Profiles (1)
Prof. Vladimir N. Anisimov, M.D., Ph.D. is referenced as a leading researcher in the following peptide research profiles on Pure U.S. Peptides:
Prof. Vladimir N. Anisimov, M.D., Ph.D. is being referenced as one of the leading scientists involved in the research and development of the peptides listed above. In no way is this doctor/scientist endorsing or advocating the purchase, sale, or use of any product for any reason. There is no affiliation or relationship, implied or otherwise, between Pure U.S. Peptides and this researcher. The purpose of citing the researcher is to acknowledge, recognize, and credit the exhaustive research and development efforts conducted by the scientists studying these peptides.